Check out LaDawn’s H.Pylori story

LaDawn’s H. pylori journey

LaDawn

Age: 57

Living with heartburn for years.

Later diagnosed with H. pylori infection.

INDICATION

What are VOQUEZNA TRIPLE PAK and VOQUEZNA DUAL PAK?

• VOQUEZNA® TRIPLE PAK® (vonoprazan tablets, amoxicillin capsules, clarithromycin tablets) and VOQUEZNA® DUAL PAK® (vonoprazan tablets, amoxicillin capsules) are co-packaged prescription medicines for the treatment of a Helicobacter pylori (H. pylori) bacterial infection in adults.
• It is not known if VOQUEZNA TRIPLE PAK and VOQUEZNA DUAL PAK are safe and effective in children.
• To reduce the development of drug-resistant bacteria and maintain the effectiveness of VOQUEZNA TRIPLE PAK, VOQUEZNA DUAL PAK and other antibacterial drugs, these products should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria.

“I am LaDawn, and I work as a financial advisor.

I first got heartburn when I was pregnant with my oldest daughter, so that’s been almost 30 years, and have dealt with it ever since. What I didn’t know was that my heartburn was likely being caused by H. pylori.

My diagnosis surprised me. I had not heard of H. pylori before. I didn’t know how I would’ve acquired this.

VOQUEZNA DUAL PAK was the treatment I didn’t know I needed.”

LaDawn took an investigational treatment regimen that was later approved as VOQUEZNA® DUAL PAK® (vonoprazan tablets, amoxicillin capsules) to treat H. pylori infection as part of the pHalconHP Phase 3 clinical study.

Two treatment regimens, namely VOQUEZNA® TRIPLE PAK® (vonoprazan tablets, amoxicillin capsules) and VOQUEZNA® DUAL PAK® (vonoprazan tablets, amoxicillin capsules), were approved by the US Food and Drug Administration on May 3, 2022, for the treatment of H. pylori infection in adults. The Prescribing Information for these regimens is available at VOQUEZNA.com/HP.

HEAR MORE FROM LADAWN NEXT

IMPORTANT SAFETY INFORMATION

Do not take VOQUEZNA DUAL PAK if you

• are known to have an allergy or be sensitive to the components of VOQUEZNA DUAL PAK (vonoprazan, amoxicillin) or penicillin.
• are taking medicines that contain rilpivirine (EDURANT, COMPLERA, JULUCA, ODEFSEY).

Please see additional Important Safety Information at the end of this video.

The patient was compensated by Phathom for her time sharing her individual experience in the trial. Individual results vary and are not generalizable across the entire study population.

“An opportunity came up to participate in a clinical trial for HP patients where I’d be taking a VOQUEZNA-based regimen. The first thing they did is confirm my HP diagnosis with a breath test.

Then I started the trial, taking medications three times a day for 14 days. During the study, everybody was very kind. They kept me fully informed with what needed to happen. If I had questions, I had numbers to call. It was a really good experience.

So at the end of the study, you did another breath test where I was then told that the H. pylori had been eradicated and—I guess like any bacterial infection—that was a really cool thing to know that it was done.

If I got HP again, I would want to take VOQUEZNA DUAL PAK, absolutely.

If someone came to me and said they’d just been diagnosed with H. pylori, I would say yes, you should ask your doctor about whether a VOQUEZNA-based regimen may be right for you. Hopefully, it can work for you as well as it worked for me.”

IMPORTANT SAFETY INFORMATION (CONTINUED)

Do not take VOQUEZNA TRIPLE PAK if you

• are known to have an allergy or be sensitive to the components of VOQUEZNA TRIPLE PAK (vonoprazan, amoxicillin, clarithromycin), macrolide antibiotics (such as azithromycin and erythromycin), or penicillin.
• are taking:
  • medicines that contain rilpivirine (EDURANT, COMPLERA, JULUCA, ODEFSEY)
  • pimozide
  • colchicine, if you have kidney or liver problems
  • lomitapide, lovastatin, and simvastatin
  • ergot alkaloids (ergotamine or dihydroergotamine)
  • lurasidone
• have a history of yellowing of the skin (jaundice) or liver problems when taking clarithromycin.

Before you take VOQUEZNA TRIPLE PAK or VOQUEZNA DUAL PAK, tell your healthcare provider about all of your medical conditions, including if you

• are pregnant, think you may be pregnant, or plan to become pregnant. It is not known if VOQUEZNA will harm your unborn baby.
• are breastfeeding. If breastfeeding, pump and discard breast milk during treatment and for 2 days after treatment.
• have kidney or liver problems.
• have myasthenia gravis.

Additionally, do not take VOQUEZNA TRIPLE PAK if:

• you are pregnant or plan to become pregnant. Clarithromycin, a medicine in VOQUEZNA TRIPLE PAK may harm your unborn baby.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. There can be serious side effects when some are used in combination with this product. Serious adverse reactions can occur with VOQUEZNA TRIPLE PAK due to drug interactions of clarithromycin with colchicine, some lipid lowering agents, some calcium channel blockers, and other drugs.

What are the possible side effects of VOQUEZNA TRIPLE PAK and VOQUEZNA DUAL PAK?
VOQUEZNA TRIPLE PAK or VOQUEZNA DUAL PAK can cause serious side effects including:

• Allergic reactions (hypersensitivity): Call your doctor right away if you have rash, hives, or other skin changes, face swelling or difficulty breathing.
• A type of kidney problem (acute tubulointerstitial nephritis): Some people who take vonoprazan, a component of VOQUEZNA TRIPLE PAK or VOQUEZNA DUAL PAK, may develop a kidney problem called acute tubulointerstitial nephritis. Call your healthcare provider right away if you have a decrease in the amount that you urinate or if you notice blood in your urine.
• Severe skin reactions: VOQUEZNA TRIPLE PAK and VOQUEZNA DUAL PAK can cause severe skin reactions, such as skin rash or allergic reaction on or in any part of your body. Symptoms can also include, but are not limited to, fever, chills, body aches or shortness of breath. If you experience any of these symptoms, stop taking VOQUEZNA TRIPLE PAK and VOQUEZNA DUAL PAK immediately and call your doctor right away.
• Gastrointestinal hypersensitivity (drug-induced enterocolitis syndrome): A type of allergic reaction that causes inflammation in the small and large intestine has been reported with use of amoxicillin, a component of VOQUEZNA TRIPLE PAK and VOQUEZNA DUAL PAK, mostly in patients ≤18 years of age. Symptoms include vomiting occurring 1 to 4 hours after taking the drug and may also be associated with skin paleness, tiredness, low blood pressure, shock, and diarrhea within 24 hours after taking amoxicillin. If you experience any of these symptoms, stop taking VOQUEZNA TRIPLE PAK or VOQUEZNA DUAL PAK and notify your doctor.
• Severe diarrhea: Call your doctor right away if you have watery stool, stomach pain, and fever that does not go away while taking VOQUEZNA TRIPLE PAK or VOQUEZNA DUAL PAK or after therapy is completed.
• Rash in patients with mononucleosis: Amoxicillin (a component of VOQUEZNA TRIPLE PAK and VOQUEZNA DUAL PAK) may cause a rash in patients who have mononucleosis. Stop taking VOQUEZNA TRIPLE PAK or VOQUEZNA DUAL PAK if you are diagnosed with mononucleosis and call your doctor right away.
• Altered test results for some tumors: VOQUEZNA TRIPLE PAK and VOQUEZNA DUAL PAK lower stomach acid which can cause increased levels of a certain protein (CgA) in your blood. When this level is increased it may alter test results for detecting some tumors. Notify your doctor of the use of VOQUEZNA TRIPLE PAK or VOQUEZNA DUAL PAK prior to blood tests.

Additionally, VOQUEZNA TRIPLE PAK can cause:

• Irregular heartbeats: Clarithromycin may cause irregular heartbeats. Call your doctor right away if you feel faint, light-headed, or feel your heart beating irregularly.
• Liver problems: Call your doctor right away if you have any of the following symptoms: weight loss, yellowing of the skin and eyes (jaundice), dark urine, rash, or pain on the right side of your abdomen.

The most common side effects may include:

• diarrhea
• temporary changes in sense of taste
• vaginal yeast infection
• stomach pain
• headache
• high blood pressure and
• cold-like symptoms

These are not all of the possible side effects of VOQUEZNA TRIPLE PAK and VOQUEZNA DUAL PAK. Call your healthcare provider for medical advice about side effects.

General information about the safe and effective use of VOQUEZNA.

Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. Do not use VOQUEZNA TRIPLE PAK or VOQUEZNA DUAL PAK for a condition for which it was not prescribed. Do not give VOQUEZNA TRIPLE PAK or VOQUEZNA DUAL PAK to other people, even if they have the same symptoms you have. It may harm them.

For more information, ask your healthcare provider or pharmacist.

You are encouraged to report suspected adverse reactions by contacting Phathom Pharmaceuticals at 1-888-775-PHAT (7428) or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Please see the link at the top of this page for full Prescribing Information for VOQUEZNA TRIPLE PAK and VOQUEZNA DUAL PAK.

© 2024 Phathom Pharmaceuticals. All rights reserved. 8/24 US-VPZ-24-0341